The fraud Supply@ME Capital behaves better than Skinbiotherapeutics, a patronising FD writes
Tomorrow sees the AGM of the insolvent fraud Supply@ME Capital (SYME) and unlike Stuart Ashman’s Skinbiotherapeutics (SBTX) it does not treat its shareholders, though they are by definition complete morons, with obvious contempt.


